Cancer Research Annual Meeting 2010 Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Venkateswaran, V.
Right arrow Articles by Fleshner, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venkateswaran, V.
Right arrow Articles by Fleshner, N. E.
[Cancer Research 62, 2540-2545, May 1, 2002]
© 2002 American Association for Cancer Research

Epidemiology and Prevention

Selenium Modulation of Cell Proliferation and Cell Cycle Biomarkers in Human Prostate Carcinoma Cell Lines

Vasundara Venkateswaran, Laurence H. Klotz and Neil E. Fleshner1

Division of Urology, Sunnybrook and Women’s College Health Science Centre, Toronto, Ontario M4N 3M5, Canada

Prostate cancer (PCA) is the most common histological malignancy and the second leading cause of cancer deaths among North American men. There has been considerable interest in the chemopreventative properties of selenium. In this study, we assessed whether selenium inhibits cell growth and associated cell cycle regulatory proteins. Human PCA cells (LNCaP, PC3, PC3-AR2, and PC3-M) were incubated with and without selenium (Seleno-DL-methionine, 150 µM) for 24, 48, and 72 h. Cells were fixed and stained with propidium iodide for flow cytometry analysis. In parallel experiments, total protein was extracted, immunoprecipitated with cyclin E antibody, and analyzed by Western blot for the expression of cell cycle markers. Treatment with selenium caused G1 arrest and an 80% reduction in the S phase of LNCaP with no effect on PC3. However, PC3 cells transfected with the androgen receptor (PC3-AR2) exhibited a G2/M arrest and a marked reduction (57%) in the S phase during cell cycle progression. In the analysis of cell cycle regulatory molecules, selenium-treated cells demonstrated a significant induction of cyclin-dependent kinase inhibitors Cip1/p21 and Kip1/p27. These data suggest that selenium possesses strong antiproliferative properties in regard to human PCA. This effect appears to be dependent on the presence of a functioning androgen receptor. This provides a theoretical basis for Phase III studies of selenium in PCA prevention.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
E. Kelly, C. M. Greene, T. P. Carroll, N. G. McElvaney, and S. J. O'Neill
Selenoprotein S/SEPS1 Modifies Endoplasmic Reticulum Stress in Z Variant {alpha}1-Antitrypsin Deficiency
J. Biol. Chem., June 19, 2009; 284(25): 16891 - 16897.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
V. Venkateswaran, L. H. Klotz, M. Ramani, L. M. Sugar, L. E. Jacob, R. K. Nam, and N. E. Fleshner
A Combination of Micronutrients Is Beneficial in Reducing the Incidence of Prostate Cancer and Increasing Survival in the Lady Transgenic Model
Cancer Prevention Research, May 1, 2009; 2(5): 473 - 483.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
N. E Allen, P. N Appleby, A. W Roddam, A. Tjonneland, N. F. Johnsen, K. Overvad, H. Boeing, S. Weikert, R. Kaaks, J. Linseisen, et al.
Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)
Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1567 - 1575.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
V. Venkateswaran, A. Q. Haddad, N. E. Fleshner, R. Fan, L. M. Sugar, R. Nam, L. H. Klotz, and M. Pollak
Association of Diet-Induced Hyperinsulinemia With Accelerated Growth of Prostate Cancer (LNCaP) Xenografts
J Natl Cancer Inst, December 5, 2007; 99(23): 1793 - 1800.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
U. Peters, C. B Foster, N. Chatterjee, A. Schatzkin, D. Reding, G. L Andriole, E D. Crawford, S. Sturup, S. J Chanock, and R. B Hayes
Serum selenium and risk of prostate cancer--a nested case-control study
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 209 - 217.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. L. Sabichi, J. J. Lee, R. J. Taylor, I. M. Thompson, B. J. Miles, C. M. Tangen, L. M. Minasian, L. L. Pisters, J. R. Caton, J. W. Basler, et al.
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
Clin. Cancer Res., April 1, 2006; 12(7 Pt 1): 2178 - 2184.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. M. Lippman, P. J. Goodman, E. A. Klein, H. L. Parnes, I. M. Thompson, A. R. Kristal, R. M. Santella, J. L. Probstfield, C. M. Moinpour, D. Albanes, et al.
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
J Natl Cancer Inst, January 19, 2005; 97(2): 94 - 102.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. Tyagi, C. Agarwal, G. Harrison, L. M. Glode, and R. Agarwal
Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages
Carcinogenesis, September 1, 2004; 25(9): 1711 - 1720.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. Venkateswaran, N. E. Fleshner, L. M. Sugar, and L. H. Klotz
Antioxidants Block Prostate Cancer in Lady Transgenic Mice
Cancer Res., August 15, 2004; 64(16): 5891 - 5896.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
P. R. Taylor, H. L. Parnes, and S. M. Lippman
Science Peels the Onion of Selenium Effects on Prostate Carcinogenesis
J Natl Cancer Inst, May 5, 2004; 96(9): 645 - 647.
[Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
H. Zhao, M. L. Whitfield, T. Xu, D. Botstein, and J. D. Brooks
Diverse Effects of Methylseleninic Acid on the Transcriptional Program of Human Prostate Cancer Cells
Mol. Biol. Cell, February 1, 2004; 15(2): 506 - 519.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
H. Zeng and C. D. Davis
Down-Regulation of Proliferating Cell Nuclear Antigen Gene Expression Occurs during Cell Cycle Arrest Induced by Human Fecal Water in Colonic HT-29 Cells
J. Nutr., August 1, 2003; 133(8): 2682 - 2687.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Wilkinson and G. W. Chodak
Critical Review of Complementary Therapies for Prostate Cancer
J. Clin. Oncol., June 1, 2003; 21(11): 2199 - 2210.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Dong, H. Zhang, L. Hawthorn, H. E. Ganther, and C. Ip
Delineation of the Molecular Basis for Selenium-induced Growth Arrest in Human Prostate Cancer Cells by Oligonucleotide Array
Cancer Res., January 1, 2003; 63(1): 52 - 59.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.